Neuronetics Inc (STIM) support and resistance · rev $74.9M
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ.
This page maps Neuronetics Inc (STIM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported STIM revenue for 2024-12-31 was $74.9M. Net income was -$43.7M. Revenue was up 5.0% from 2023-12-31 to 2024-12-31. STIM currently screens at market cap $84.2M.
STIM currently screens at market cap $84.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new STIM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the STIM quote page for the session range and the stock page for the full model.
Not investment advice.